The Leber Congenital Amaurosis market driven by gene therapy advancements

0
401

The Leber congenital amaurosis market is experiencing rapid growth due to advancements in gene therapy technology that can potentially restore vision in patients. Leber congenital amaurosis is a group of inherited retinal disorders caused by mutations in any one of at least 18 genes and is the leading cause of inherited childhood blindness. Gene therapies aim to replace the defective gene responsible for vision loss and help retain or improve visual functions. Some key ongoing clinical trials evaluating gene therapies such as Luxturna, voretigene neparvovec, and RGX-314 are showing promising results in restoring sight in people suffering from Leber congenital amaurosis.

The Global Leber Congenital Amaurosis Market is estimated to be valued at US$ 1.23 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Leber Congenital Amaurosis Market Demand are Novartis, Biogen, Spark Therapeutics, GenSight Biologics, Roche, AbbVie, Regeneron Pharmaceuticals, Pfizer, Astellas Pharma, Santen Pharmaceutical, Orphan Biovitrum, Apellis Pharmaceuticals, Gilead Sciences, Eyenovia, Avexis, Regenxbio, Horizon Therapeutics, Aerie Pharmaceuticals, Ophthotech Corporation, and Aldeyra Therapeutics. Key players are involved in developing novel gene therapies and obtaining regulatory approvals to commercialize their products.

The growing demand for vision-restoration therapies is a major factor fueling market growth. With no approved treatment options available, the introduction of advanced gene therapies is generating significant optimism among patients and healthcare professionals. Furthermore, ongoing research into understanding genetic causes of Leber congenital amaurosis is also helping the development of new treatment options.

Globally, North America dominated the Leber congenital amaurosis market in 2020 owing to favorable reimbursement policies and the presence of advanced healthcare facilities. However, the Asia Pacific region is expected to exhibit the fastest growth over the forecast period thanks to improving access to healthcare in emerging economies, rising healthcare spending, and a growing patient pool with vision disorders.

Get more insights Leber Congenital Amaurosis market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

البحث
إعلان مُمول
الأقسام
إقرأ المزيد
Shopping
Mike Conley Kids Jersey
If you think you happen to be alone when it comes to managing your psoriasis Tyreke Evans...
بواسطة Sun Abb منذ ٥ سنوات 0 2كيلو بايت
Literature
Cold Mix Asphalt Additives Market is Probable to Influence the Growth of 3.90% By 2030
A new research study on the global Cold Mix Asphalt Additives Market size 2023-2030 provides an...
بواسطة Dipti Ghadge منذ سنة 0 1كيلو بايت
أخرى
Dubai Indian Escort Service +971506317606
If you live in Dubai, you live a beautiful life and since it is more convenient than others, you...
بواسطة Aanu Singh منذ ٩ أيام 0 27
Health
A Guide to Individual Health Insurance in Bradford, CT
In the present speedy world, guaranteeing your well-being and prosperity is vital. This article...
بواسطة Individualhealthinsurance Bradfordct منذ ٧ أشهر 0 853
Health
Choosing the Right Provider: Navigating the Liquid Facelift Market in Dubai
Liquid Facelift in Dubai, where eminence rules are high and restorative upgrades are ordinary,...
بواسطة Aiza Batool منذ ٨ أشهر 0 679